{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/2082382492",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1241346749"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1989346800",
    "http://id.who.int/icd/release/11/2024-01/mms/1543645234",
    "http://id.who.int/icd/release/11/2024-01/mms/1452248926"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#2082382492",
  "code": "XM6WD2",
  "source": "http://id.who.int/icd/entity/2082382492",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Anticholinergics predominantly used for Parkinson disease"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Anticholinergics predominantly used for Parkinson disease"
      }
    }
  ]
}